John K. Nelson
About John K. Nelson
Independent Board Member of Nuveen Real Asset Income and Growth Fund (JRI) since 2013; Class II trustee with a term expiring at the 2026 annual shareholder meeting. Former CEO of ABN AMRO Bank N.V., North America and Global Head of Financial Markets; Senior External Advisor to Deloitte Consulting (2012–2014). Education: BA Economics and MBA Finance, Fordham University. Born 1962; designated an SEC “audit committee financial expert” and currently serves as Chair of the Audit Committee; oversees 218 Nuveen portfolios across the fund complex.
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| ABN AMRO Bank N.V. (incl. LaSalle Bank) | CEO, North America; Global Head, Financial Markets Division; various executive roles | 1996–2008; CEO/Global Head 2007–2008 | Led global FX/commodities/fixed income/derivatives; represented bank on committees of the Bank of Canada, ECB, BoE; member of the Fed FX Committee. |
| Deloitte Consulting LLP | Senior External Advisor (Financial Services practice) | 2012–2014 | Advisory expertise to financial services clients. |
| Core12 LLC (private) | Director | 2008–2023 | Branding/marketing firm board service. |
| Fordham University | President’s Council (Director) | 2010–2019 | University advisory role. |
| Curran Center for Catholic American Studies (Fordham) | Director | 2009–2018 | Board service. |
| Marian University | Trustee and Chairman of the Board of Trustees | 2011–2013 | Board leadership. |
External Roles
| Category | Entity | Role | Status/Years |
|---|---|---|---|
| Private Company | Core12 LLC | Director | 2008–2023 (former) |
| Academic/Non-profit | Fordham University President’s Council | Director | 2010–2019 (former) |
| Academic/Non-profit | Curran Center for Catholic American Studies (Fordham) | Director | 2009–2018 (former) |
| Academic/Non-profit | Marian University | Trustee; Chairman, Board of Trustees | 2011–2013 (former) |
| Public company directorships (last five years) | — | — | None disclosed in proxy (Other Directorships field lists only Core12/private/academic) |
Board Governance
- Independence and classification: Listed among “Board Members/Nominees who are not ‘interested persons’” (independent) and serves as a Class II Board Member with term to 2026.
- Committee leadership and financial expertise: Audit Committee Chair; designated SEC “audit committee financial expert.”
- Committee memberships: Executive Committee (member); Dividend Committee (member); Nominating & Governance Committee (member); Investment Committee (member); Closed-End Fund Committee (member).
- Meeting cadence and attendance: For JRI’s last fiscal year, meetings held: Board regular (5), Board special (9), Executive (5), Dividend (10), Compliance (5), Audit (14), Nominating & Governance (5), Investment (4), Closed-End Fund (4). Each Board Member attended ≥75% of Board and applicable committee meetings.
Fixed Compensation
- Structure evolution:
- 2023: $210,000 annual retainer; per-meeting fees (e.g., $7,250 regularly scheduled board day; $2,500 Audit/Closed-End/Investment; $5,000 Compliance/Risk; $1,250 Dividend; $500 other committees), plus chair retainers ($20,000 for committee chairs; $140,000 Board Chair).
- Effective Jan 1, 2024 (and stepped-up Jan 1, 2025): $350,000 base retainer; committee membership annual retainers ($30,000→$35,000 Audit and Compliance; $20,000→$30,000 Investment; $20,000→$25,000 Dividend, Nominating & Governance, Closed-End). Chair retainers: Board Chair $140,000→$150,000; Audit/Compliance Chair $30,000→$35,000; Investment Chair $20,000→$30,000; Dividend/Nominating/Closed-End Chair $20,000→$25,000; ad hoc meetings $1,000 or $2,500 per meeting; special assignment committee fees.
| Item | Amount/Terms |
|---|---|
| Aggregate compensation paid by JRI to Nelson (last fiscal year) | $1,489 |
| Total compensation from funds in Nuveen Fund Complex paid to Nelson (last fiscal year) | $483,250 |
| Deferred compensation plan availability | Plan allows deferral into book accounts tied to eligible Nuveen funds; no pension/retirement plans for Funds. |
Performance Compensation
- No performance-based incentives or equity grants are disclosed for independent Board Members; compensation consists of retainers and committee fees (with optional fee deferral).
| Performance-linked element | Disclosed? | Notes |
|---|---|---|
| Cash bonus tied to KPIs (TSR, EBITDA, etc.) | No | Not applicable to independent fund directors. |
| Equity awards (RSU/PSU/options) | No | Not disclosed for directors; only fee deferral to fund equivalents is available. |
| Clawbacks/COC provisions for directors | No | Not discussed for independent Board Members. |
Other Directorships & Interlocks
| Type | Company | Role | Potential Interlock/Conflict Notes |
|---|---|---|---|
| Public company boards | — | — | None disclosed for Nelson in past five years. |
| Holdings in adviser-affiliated private companies | — | — | Appendix shows such holdings for another director (T. Kenny) but none for Nelson. |
Expertise & Qualifications
- Audit and financial oversight: SEC “audit committee financial expert” and Audit Committee Chair; long tenure overseeing audit/valuation, auditor independence, and financial reporting.
- Global markets leadership: Led ABN AMRO’s Financial Markets Division (FX, commodities, fixed income, EM, derivatives) and served as CEO, North America.
- Policy/market committees: Served on the Federal Reserve FX Committee; interacted with Bank of Canada, ECB, and Bank of England committees during ABN AMRO tenure.
- Education: BA Economics; MBA Finance (Fordham University).
Equity Ownership
| Measure | JRI (Real Asset) | Fund Complex Aggregate |
|---|---|---|
| Shares owned (12/31/2024) | 0 | — |
| Dollar range in JRI | $0 | — |
| Ownership as % of JRI outstanding | 0% (each director <1% per fund as of 2/18/2025) | — |
| Aggregate range across all registered investment companies overseen | — | Over $100,000 (Nelson) |
| Deferred fees balance (JRI) | None indicated for Nelson (dash in table) | — |
| Shares pledged/hedged | Not disclosed | Not disclosed |
Governance Assessment
-
Strengths
- Deep markets and risk expertise; designated audit committee financial expert and Audit Committee Chair enhances financial reporting oversight and valuation governance.
- Broad committee participation (Audit Chair; Executive/Dividend/Nominating/Investment/Closed-End member) signals high engagement and influence on distribution policy, investment oversight, discount management, and governance processes.
- Attendance: At least 75% of Board and applicable committee meetings during the last fiscal year; JRI had a heavy meeting load (e.g., 14 Audit, 10 Dividend), indicating active governance cadence.
-
Alignment and risks
- Low direct ownership in JRI (0 shares; $0 dollar range) can be perceived as weaker fund-level alignment, though he reports over $100,000 invested across the Nuveen family of funds.
- Compensation shift increases guaranteed retainers and committee retainers (2024–2025 increases), reducing pay-at-risk and potentially elevating pay inflation risk; however, it better reflects workload and reduces meeting-by-meeting incentives.
- No related-party holdings or adviser-affiliated company investments disclosed for Nelson (contrast: another director disclosed such holdings), supporting independence and lower conflict risk.
-
Red flags
- None evident related to legal proceedings, pledged shares, or related-party transactions for Nelson in the proxy; continuous monitoring recommended.
Board Governance (Committee Detail Snapshot)
| Committee | Role | JRI Meetings Held (last FY) |
|---|---|---|
| Audit | Chair; SEC “financial expert” | 14 |
| Executive | Member | 5 |
| Dividend | Member | 10 |
| Nominating & Governance | Member | 5 |
| Investment | Member | 4 |
| Closed-End Fund | Member | 4 |
Note: Each Board Member attended ≥75% of Board and committee meetings during the last fiscal year.
Director Compensation (JRI and Complex)
| Scope | Amount |
|---|---|
| JRI aggregate compensation to Nelson (last FY) | $1,489 |
| Total compensation from Nuveen Fund Complex to Nelson (last FY) | $483,250 |
Independent Board Member compensation in 2023 relied on per-meeting fees; effective Jan 1, 2024 (stepping up Jan 1, 2025), compensation moved to higher base retainers plus committee membership and chair retainers; ad hoc meeting fees apply; fee deferral program available; no pension plans.
Other Notes
- Election/tenure: Class II; term to 2026 annual meeting; joined Board in 2013.
- Independence: Listed among non-“interested persons”; Audit Committee comprised entirely of independent members per NYSE/NASDAQ standards.